國家衛生研究院 NHRI:Item 3990099045/2706
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915175      Online Users : 1378
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2706


    Title: Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population
    Authors: Huang, SP;Chou, YH;Chang, WSW;Wu, MT;Chen, YY;Yu, CC;Wu, TT;Lee, YH;Huang, JK;Wu, WJ;Huang, CH
    Contributors: National Institute of Cancer Research
    Abstract: Recent molecular epidemiological studies have shown that the inherited polymorphisms of VDR gene may be linked to prostate cancer risk and its aggressive phenotypes. However, the findings remain inconclusive. In this study, we investigated the association of the BsmI, ApaI and TaqI polymorphisms of VDR gene with prostate cancer risk in a Taiwanese population. In total, 160 prostate cancer patients and 205 age-matched male controls were studied between December 2000 and February 2003. No significant associations were found between the ApaI and TaqI polymorphisms and the risk of prostate cancer. However, the control group was found to have a significantly higher frequency of the BsmI `BB' and `Bb' genotypes (15.6%) than prostate cancer patients (8.1%). After adjustment for age, patients with Bsm I `BB' or `Bb' genotypes were associated with a twofold decreased risk (OR = 0.50; 95%CI = 0.25-0.98; P = 0.045) for developing prostate cancer than those with `bb' genotypes. This effect was particularly significant among men below the median age of 72 years (P = 0.017). Moreover, stronger associations were found in the advanced stages (T3/T4/N1/M1) and poorly differentiated disease (Gleason score greater than or equal to 7) (`BB' and `Bb' vs `bb': OR = 0.25; 95%CI = 0.07-0.83; P = 0.024 and OR = 0.25; 95%CI = 0.07-0.85; P = 0.026, respectively). Our findings suggest that the VDR BsmI polymorphism may play a significant role in the development of prostate cancer. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
    Keywords: Oncology
    Date: 2004-04-15
    Relation: Cancer Letters. 2004 Apr;207(1):69-77.
    Link to: http://dx.doi.org/10.1016/j.canlet.2003.12.006
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0304-3835&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000220931600008
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=12144289486
    Appears in Collections:[Wun-Shaing Wayne Chang] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000220931600008.pdf145KbAdobe PDF801View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback